Editorial board

Executive Editor
Anna Radominska-Pandya - Professor Emeritus, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Associate Editors
B. Clement - Professor i. R. (Emeritus) of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Faculty of Mathematics and Natural Sciences, Christian Albrechts - Universitat Kiel, Kiel, Germany
C. Khojasteh - Senior Director and Distinguished Scientist, Genentech Inc., South San Francisco, CA, USA
Grover P. Miller - Professor, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, AR, USA
M. Ronis - Professor Emeritus, Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA

Editorial Board
M. Baciut - Professor of Oral and Maxillofacial Surgery and Implantology, Faculty of Dental Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
T. Baillie - Professor and Dean Emeritus, Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA
A. S. Biris - Director/Chief Scientist, Center for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, USA
M. Coughtrie - Professor of Biochemical Pharmacology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada
D. Dalvie - VP Drug Metabolism and Pharmacokinetics, Crinetics Pharmaceuticals, San Diego, CA, USA
C. Falany - Professor Emeritus, Department of Pharmacology and Toxicology, University of Alabama Birmingham, Birmingham, AL, USA
R. Fujiwara -Assistant Professor, Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH, USA
T. Fukami - Associate Professor of Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan
C. Guillemette - Professor and Canada Research Chair in Pharmacogenomics, Faculty of Pharmacy, Université Laval, Quebec City, Quebec, QC, Canada
J. H. Hartman - Assistant Professor, Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA
J. M. Heydel - Professor of Biochemistry and Molecular Biology, Faculty of Pharmacy & Health Sciences, University of Burgundy, Dijon, France
S. Ikushiro - Professor of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Toyama, Japan
Y. Ishii - Associate Professor, Division of Pharmaceutical Cell Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan
A. Jee - PhD Candidate, Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
M. Jukic - Associate Professor, Department of Physiology, Faculty of Pharmacy, University of Belgrade, Serbia; Section for Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
V. Lauschke - Professor of Translational Pharmacology, Karolinska Institutet, Stockholm, Sweden; Sweden and Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
P. I. Mackenzie - Professor Emeritus, Clinical Pharmacology, College of Medicine and Public Health, Flinders University of South Australia, Adelaide, SA, Australia
J. E. Manautou - Chair in Mechanistic Toxicology, Boehringer Ingelheim Pharmaceuticals, Inc; Department Head of Pharmaceutical Sciences and Professor of Toxicology, School of Pharmacy, University of Connecticut, Storrs, CT, USA
R. Meech - Professor/Discipline Lead, Discipline of Clinical Pharmacology, Flinders Health and Medical Research Institute (FHMRI), Flinders University. Adelaide, SA, Australia
J. O. Miners - Matthew Flinders Distinguished Professor Emeritus, College of Medicine and Public Health, Flinders University, Adelaide, Australia
C. Nwabufo - PhD candidate, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
F. Oesch - Emeritus Professor of Toxicology and Pharmacology, Faculty of Medicine, Johannes Gutenberg University, University of Mainz, Mainz, Germany
P. L. Prather - Professor, Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA
I. M. C. M. Rietjens - Professor in Toxicology, Division of Toxicology, Wageningen University, Netherlands
L. Russell - Senior Scientist, AbbVie, South San Francisco, CA, USA
E. E. Scott - F. F. Blicke Collegiate Professor of Pharmacy; Professor, Departments of Medicinal Chemistry and Pharmacology; Faculty Director, BioNMR Core Lab, University of Michigan, Ann Arbor, MI, USA
A. J. Tackett - Distinguished Professor of Biochemistry and Molecular Biology, Department of Biochemistry and Molecular Biology, College of Medicine,
University of Arkansas for Medical Sciences, Arkansas, USA
R. Totah - Professor of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, USA
R. Tyndale - Canada Research Chair in Pharmacogenomics, Professor of Pharmacology, Toxicology and Psychiatry, Centre for Addiction and Mental Health and University of Toronto, Toronto, Canada
J. P. Uetrecht - Professor of Clinical Pharmacy Research, Drug Safety, Molecular Basis of Drug Targets & Diseases, Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada
N. P. E. Vermeulen - Professor Emeritus. Molecular Toxicology, VU University, Amsterdam, Netherlands
C. Roland Wolf - Professor of Molecular Pharmacology, School of Medicine, University of Dundee, Dundee, UK
W. Xie - Professor of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA
Y. Yamazoe - Emeritus Professor, Tohoku University, Sendai, Japan

Special Section of the Editorial Board (working with Dr. Cyrus Khojasteh):
I. M. C. M. Rietjens - Professor in Toxicology, Division of Toxicology, Wageningen University, Netherlands
D. Dalvie - VP Drug Metabolism and Pharmacokinetics, Crinetics Pharmaceuticals, San Diego, CA, USA

Founding Editor
Frederick J. Di Carlo